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The development of nonviral synthetic vectors for clinical application of gene therapy using siRNA
transfection technology is of particular importance for treatment of human diseases, which is yet an
unsolved challenge. By employing a rational design approach, we have synthesized a set of well-deﬁned,
low-molecular-weight dendritic polyglycerol-based amphiphiles, which are decorated peripherally with
the DAPMA (N,N-di-(3-aminopropyl)-N-(methyl)amine) moiety. The main diﬀerences that were
introduced in the structural motif relate to dendron generation and the type of linker between the
hydrophilic and hydrophobic segment. The synthesized amphiphiles were then characterized for their
aggregation behaviour and further evaluated with respect to their siRNA transfection potential by
comparing their physico-chemical and biological features. Our ﬁndings demonstrated that all four
synthesized amphiphiles yielded high gene binding aﬃnities. Furthermore, the ester-linked compounds
(G1-Ester-DAPMA, G2-Ester-DAPMA) revealed noticeable gene silencing in vitro without aﬀecting the
cell viability in the tumor cell line 786-O. Remarkably, neither G1-Ester-DAPMA nor G2-Ester-DAPMA
induced inﬂammatory side eﬀects after systemic administration in vivo, which is noteworthy because
such highly positively charged compounds are typically associated with toxicity concerns which in turn
supports their prospective application for in vivo purposes. Therefore, we believe that these structures
may serve as new promising alternatives for nonviral siRNA delivery systems and have great potential for
further synthetic modiﬁcations.Introduction
Gene therapy holds substantial promise for the treatment of
inherited and acquired diseases such as cystic brosis, HIV,
arthritis, cancer, and other medical conditions.1–3 It is based on
correcting the origin of diseases by delivery and subsequent
expression of exogenous genetic materials, either RNA or DNA,
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hemistry 2014unwanted gene expression, or introduce new cellular func-
tions.4,5 In recent years, the antisense approach has been
regarded as particularly promising, which involves the intra-
cellular delivery of antisense constructs that usually lead to a
reduction of target activity, termed gene silencing.6 Nonviral
gene carriers including the main classes of cationic polymers
and lipids have been extensively studied for two decades now as
alternatives to viral vectors due to their improved safety, greater
synthetic tunability and versatility, larger capacity for thera-
peutic genes, and more facile manufacturing.7–15 However, low
transfection eﬃciencies and toxicity issues still remain major
barriers for clinical application of nonviral gene therapy.16–18
Among the nonviral nanocarriers, dendrimers have been
utilized and examined in biomedical elds for drug and gene
delivery systems because of their dened molecular structures,
versatility with regard to molecular size and surface chemistry,
intrinsic multivalent features, and high cargo payload at
nanosized dimensions.19–24 Developing dendrimers as nano-
vectors to deliver RNA therapeutics, especially synthetic small
interfering RNAs (siRNAs), and to employ them for the specic
inhibition and knockdown of disease genes by RNA interference
(RNAi) is one of the most promising pathways within the eld ofJ. Mater. Chem. B, 2014, 2, 2153–2167 | 2153




























































































View Article Onlinegene therapy.25–30 The main challenge lies in the safe and eﬃ-
cient delivery of siRNA. An optimal gene vector has to fulll
specic requirements in order to successfully transfect cells
both in vitro and in vivo. Foremost, the transporter needs to
complex and condense the genetic material, protect it from
nucleolytic degradation, enable cellular uptake, and nally
release it from the endosomal pathway into the cytosol, where
the RNAi machinery is located.31
Although high molecular weight dendrimers like PAMAM
(poly(amidoamine)),7,32,33 PPI (poly(propylene imine)),34–36 and
PEI (poly(ethylenimine))37–39 can lead to high transfection eﬃ-
ciencies, they also exhibit problematic toxicity proles,40 which
can be partially attributed to their cellular accumulation aer
gene delivery has taken place.41 An alternative approach, mainly
established and advanced by Florence,42 Sanya,43 Diederich,44
and Smith,45 was to modify low-molecular-weight, amine-func-
tionalized dendritic arrays with hydrophobic portions to
promote their self-assembly into supramolecular dendrimers
(“pseudodendrimers”). In this way, positively charged large
multivalent arrays are generated that are suitable for gene
delivery applications (Fig. 1).
Our research group has previously proven that such a
strategy can enhance gene delivery and lead to synergistic
eﬀects if aspects of both classes of nonviral gene delivery, i.e.,
polymers and lipids, are combined,27 which also has been
demonstrated with related architectures.17,45–48 In fact, along
with a recent report by Peng and co-workers,28 this was one of
the rst successful examples of in vitro siRNA transfection using
dendritic amphiphiles.27 More specically, we developedFig. 1 Concept of self-assembling amphiphiles used for gene delivery a
Fig. 2 Dendritic amphiphiles investigated in this study (A1 ¼ G1-Ester-
DAPMA).
2154 | J. Mater. Chem. B, 2014, 2, 2153–2167glycine-functionalized amphiphiles based on polyglycerol den-
drons that had successfully delivered luciferase and GAPDH
siRNA into HeLa cells.27 Interestingly, one candidate (G2-octa-
amine) with eight amine groups on its surface and a hydro-
phobic C-18 alkyl chain at the core acted as an eﬃcient siRNA
vector and still remained non-toxic, even at high N/P ratios (e.g.,
N/P of 100).
In an endeavor to create a gene vector which is eﬃcient and
safe for both in vitro and in vivo applications, we have now
adopted the same structural motif but incorporated distinctive
structural variations with respect to the employed amine moiety
as well as the type of linker between the hydrophilic and
hydrophobic domains (Fig. 2).
On the surface of the dendritic head group of the amphi-
philes, we attached DAPMA, an amine functionality that has
already proven to be an eﬀective entity for gene delivery appli-
cations.41,49 With reference to the linkage, we decided to inte-
grate exible, biodegradable ester functionalities (A1, A2) in
contrast to rigid, non-degradable triazole groups (A3, A4), to
assist the eﬀective release of the genetic cargo. It is known that
micelles with biodegradable features can enhance polyplex
dissociation and thus improve transfection eﬃciency.50,51 The
integration of rigid elements has also been shown to have a
benecial eﬀect with respect to biocompatibility and trans-
fection properties.44,52
Systematically, we investigated these amphiphilic dendrons
for their aggregation behaviour and further evaluated their
siRNA transfection potential by employing diﬀerent kinds of
physico-chemical and biological techniques. The obtainedpplications.
DAPMA, A2 ¼ G2-Ester-DAPMA, A3 ¼ G1-Trz-DAPMA, A4 ¼ G2-Trz-
This journal is © The Royal Society of Chemistry 2014




























































































View Article Onlineresults demonstrate that all constructs lead to a comparably
strong gene binding. However, only the ester-bridged amphi-
philes (A1, A2) revealed no cytotoxic eﬀects and caused
reasonable gene silencing in 786-O tumor cells in vitro. Notably,
systemic administration of A1 and A2 in mice demonstrated
that these constructs do not induce inammatory side eﬀects,
which renders these novel architectures highly interesting for
siRNA delivery in future applications of therapeutic RNAs.Experimental section
Materials
Air and moisture sensitive reactions were carried out in dried
glassware under an argon atmosphere. Anhydrous solvents were
either commercially purchased from Acros Organics™ in
septum-sealed bottles or chemically dried using a MBRAUN SPS
800 solvent purication system. Compounds 2, 3, and 10 were
synthesized according to reported procedures.49,53 All other
chemicals were of reagent grade quality and used without
further purication from the suppliers Acros Organics™,
Fluka®, Sigma-Aldrich®, Roth®, Invitrogen™, and Merck™.Measurements
Chromatography, spectroscopy, and spectrometry. Thin
layer chromatography (TLC) analysis was carried out on silica-
coated aluminium plates from Merck™ either using silica gel
60, F254, or silica gel 60 RP-18 F254s. Preparative column chro-
matography was conducted on silica gel 60 (0.040–0.063 mm,
230–400 mesh ASTM). Detection was accomplished by UV irra-
diation (254 nm; 366 nm) and diﬀerent staining solutions such
as potassium permanganate, cerium molybdate, ninhydrin,
bromocresol green and Dragendorﬀ reagent. Size-exclusion
chromatography (SEC) was employed by using Sephadex® LH-
20 (from GE Healthcare).
NMR spectra were recorded on a Bruker™ ECX 400 (1H: 400
MHz, 13C: 100.5 MHz), a Jeol™ Eclipse (1H: 500 MHz, 13C: 125.8
MHz), or on a Bruker™ Biospin (1H: 700 MHz, 13C: 176.1 MHz)
spectrometer at 25 C in deuterated chloroform (CDCl3),
methanol (CD3OD), or water (D2O). Chemical shis (d) are given
in parts per million (ppm) according to calibration to the cor-
responding solvents CDCl3 (
1H: 7.26 ppm, 13C: 77.00 ppm),
CD3OD (
1H: 4.87 ppm, 13C: 49.05 ppm), and D2O (
1H: 4.79 ppm).
13C NMR spectra were recorded with 1H broadband decoupling.
Multiplicities are indicated by s (singlet), d (doublet), t (triplet),
q (quartet), quin (quintet), and m (multiplet). Coupling
constants (J) are given in Hz.
Electrospray-ionization time-of-ight mass spectrometry
(ESI-TOF-MS) experiments were carried out using an Agilent
6210 ESI-TOF, Agilent Technologies™. The calculated masses
refer to the respective isotopes with the highest intensity. The
measured masses typically represent the main MS peak, while
the found isotope pattern intensities matched those calculated.
Critical micelle concentration (CMC). The critical micelle
concentration (CMC) was determined in buﬀered aqueous
solution (HEPES saline buﬀer, 9.4 mM NaCl, pH 7.4) by using
the methodology of pyrene uorescence probing.54This journal is © The Royal Society of Chemistry 2014Fluorescence emission spectra were taken using a Jasco FP-6500
spectrouorimeter equipped with a thermostated cell holder, a
DC-powered 150 W xenon lamp, a Hamamatsu R928 photo-
multiplier, and a variable slit system. Both excitation and
emission slits were set at 3 nm. The uorescence of pyrene was
recorded from 350 to 600 nm aer excitation at 330 nm. Prior to
measurements, a pyrene stock solution of 1 mM (in HEPES
saline buﬀer, 9.4 mMNaCl, pH 7.4) was freshly prepared by rst
dissolving pyrene in a small amount of methanol, evaporating
the solvent until dryness through slow passage of N2, followed
by the addition of buﬀer. Aer complete pyrene solubilization
and dilution to 0.5 mM, the amphiphiles were added as solid in
varying amounts (1 mM–10 mM). The solutions were kept for 2 h
at room temperature to promote the self-assembly process.
Fluorescence measurements were carried out at 22  2 C and
taken in triplicate and averaged.
Cryo-transmission electron microscopy (cryo-TEM). For all
sample preparations, aqueous amphiphile solutions were used
at a concentration of 4.5  103 M. Droplets of the corre-
sponding sample solution (5 ml) were applied to perforated
(1 mm hole diameter) carbon lm covered 200 mesh copper
grids (R1/4batch of Quantifoil Micro Tools GmbH, Jena, Ger-
many), which had been hydrophilized prior to use by 60 s
plasma treatment at 8 W in a BALTEC MED 020 device. The
supernatant uid was removed with a lter paper until an ultra-
thin layer spanning the holes of the carbon lm was obtained.
The samples were immediately vitried by propelling the grids
into liquid ethane at its freezing point (90 K) and by operating a
guillotine-like plunging device. The vitried samples were
transferred under liquid nitrogen cooling into a Tecnai F20 FEG
transmission electron microscope (FEI Company, Oregon, USA)
using the Gatan (Gatan Inc., California, USA) cryoholder and
-stage (model 626). Microscopy was carried out at 94 K sample
temperature using the microscope's low dose protocol at a
calibrated primary magnication of 50 000 and an accelerating
voltage of 160 kV (FEG-illumination). Images were recorded
using an EAGLE 4k-CCD camera (FEI Company, Oregon, USA)
operated with binning factor 2 (2048 by 2048 pixel). The defocus
was chosen in all cases to be 2 m. It is important to note that
although the determined diameter measurements were prone
to error due to the very small size of the assemblies, more
reliable diameter values could be derived from sample areas
where micelles were densely packed. Fourier transforms of
corresponding images revealed a diﬀraction pattern which
indicates repetitive distances which can be said to correlate with
the diameter of the micelles (cf. Fig. 3B).
DLS and zeta potential. DLS and zeta potential measure-
ments were conducted at 25 C using a Zetasizer Nano ZS
analyzer™ with an integrated 4 mW He–Ne laser, l ¼ 633 nm
(Malvern Instruments™ Ltd, U.K.). The amphiphiles were
measured in HEPES saline buﬀer (2 mM, EDTA 10 mM, NaCl
9.4 mM) or in phosphate buﬀer (10 mM) at pH 7.4. Polyplex
solutions were obtained as follows: rst a 200 mM DNA (21-mer
oligonucleotides) solution was freshly prepared in HEPES buﬀer
solution. With respect to a certain N/P ratio, the appropriate
amount of amphiphile was added. It should be noted that the
concentrations of the respective amphiphiles during polyplexJ. Mater. Chem. B, 2014, 2, 2153–2167 | 2155
Fig. 3 Representative cryo-TEM images of G1-Ester-DAPMA (A1). (A)
Small spherical particles with diameters of 3–5 nm coexist with (B)
extended two-dimensional arrays possessing a hexagonal ultrastruc-
ture. Fourier transform of these arrays reveals a repetitive distance of
4.44 nm indicating a highly ordered packing of A1.




























































































View Article Onlineformation were above each CMC. Aer mixing and incubation
for 30 min, the sample solutions were diluted and directly
measured. All measurements were carried out using folded
capillary cells (DTS 1060) in three replicate measurements.
Ethidium bromide displacement assay. The experimental
protocol for the ethidium bromide (EthBr) displacement assay
is based on reported procedures.55–58 Fluorescence spectroscopy
measurements were performed using a JASCO FP-6500 spec-
trouorometer using an excitation wavelength of 520 nm. The
uorescence intensity of samples at diﬀerent N/P ratios was
recorded from 560 to 700 nm. The DNA binding properties were
studied at low salt concentration in HEPES saline buﬀer (pH
7.4, 2 mM HEPES, 9.4 mM NaCl), supplemented with EthBr
(1.26 mM). Solutions containing DNA (21-mer oligonucleotides)
and EthBr in buﬀer were rst incubated at room temperature
for 5 min to ensure interactions. Consequently, an appropriate
quantity of the corresponding amphiphile was added in order to
reach the desired N/P ratio. The uorescence of the DNA solu-
tion with EthBr was set at 100%. The uorescence values were
normalized against the set 100% value and expressed as relative
reduction of the uorescence intensity. Control experiments
were conducted by measuring solutions which only contained
EthBr and amphiphiles. Experiments were performed in
triplicate.
Agarose gel electrophoresis. The siRNA–amphiphile inter-
actions were measured by means of agarose gel electrophoresis
retardation assay employing FAM-labeled siRNA (GUCAACG-
GAUUUGGUCGUA, synthesized by Eurogentec).27 One day prior
to electrophoresis the amphiphiles A1–A4 were dissolved in
double distilled water. The uorescently labeled siRNA was
complexed with each amphiphile solution by incubation for
30 min at room temperature. Here, it was ensured that the
concentrations were above the respective CMCs of the amphi-
philes. The polyplexes were then loaded on 4% high-resolution
agarose gels (MetaPhor Agarose, Lonza) and subjected to elec-
trophoresis at 70 V. The labeled siRNA complexes were visual-
ized aer excitation at 495 nm using the Fusion SL imager
(Vilber Lourmat).
Cell culture. Cell viability and cytotoxicity studies were per-
formed with the cell line HeLa (ATCC no. CCL-2), which was2156 | J. Mater. Chem. B, 2014, 2, 2153–2167cultured at 37 C and 5% CO2 in RPMI 1640 medium (Bio-
chrom), supplemented with 10% fetal bovine serum
(Biochrom). In addition, the human renal carcinoma cell line
786-O-Luc, constitutively expressing the rey luciferase, was
used for transfection and simultaneous cell viability studies.
786-O-Luc cells were cultured in growth medium composed of
RPMI 1640 (Biochrom), supplemented with 10% FCS, 1%
200 mM glutamine, 1% 100 mM pyruvate, 1% 1 M HEPES, 4.5 g
L1 glucose and 50 mg mL1 hygromycin B at 37 C, 5% CO2. As
a general note, it should be pointed out that the concentrations
of the respective amphiphiles during polyplex formation were
above each CMC. Aer mixing and incubation with siRNA for
30 min, the sample solutions were diluted and directly
subjected to the relevant cells.
Cell viability and cytotoxicity assays. Cytotoxicity and cell
viability were measured using the end-point viability WST-1
assay (Roche) as well as the xCELLigence system (Roche) for
continuous monitoring of cell viability and growth in real-time,
as described previously.27 The assays were conducted 24 hours
aer seeding 1  104 HeLa cells per well in 96-well plates using
the amphiphiles A1–A4 and Lipofectamine 2000 transfection
reagent (Invitrogen) as the positive control. Untreated cells
served as the negative control (termed “Control”). Each plate
contained blanks, controls, and serial dilutions of the
substances in four replicates. The WST-1 assay was performed
according to the manufacturer's instructions and carried out
with non-targeting siRNA (ON-TARGETplus Non-targeting
siRNA, Dharmacon). The colorimetric WST-1 assay is based on
the enzymatic cleavage of the tetrazolium salt WST-1 to for-
mazan by cellular mitochondrial dehydrogenases present in
metabolically active cells. It directly reects the number of
viable cells in culture. The xCELLigence system allows contin-
uous cell monitoring by measuring the impedance via inte-
grated microelectrodes on the bottom of each well. The
electrode impedance, displayed as Cell Index (CI) values,
increases with the amount of attached cells on the electrodes. In
addition, cell interactions with the electrodes due to
morphology aﬀect the impedance. Therefore, the CI values
reect the biological state of monitored cells, including the cell
number, viability, adhesion, and morphology. The xCELLigence
experiment was divided into three parts: background
measurement, cell monitoring and compound activity moni-
toring. For each treatment quadruplicate wells were used for
statistical analysis. 50 mL of medium was added to each well and
the plate was adjusted for 15 min at room temperature. Aer
transferring the E-plate (Roche) to the Real-Time Cell Analyzer
(RTCA) instrument, a second equilibration step for another
15 min in the incubator (37 C, 5% CO2) was performed.
Thereaer the experiment started by measuring the back-
ground of the medium. Then, the E-plate was taken out and 100
mL cell suspension (1  104 cells per well) was added to the
wells. The E-plate was le for 15 min on a clean bench allowing
even distribution of cells. The E-plate was put in the RTCA
instrument and aer 15 min for pH adjustment the cell moni-
toring step (measurement every 15 min for 24 h) was started.
Aer 24 h, the medium was changed (removal of 100 mL old
medium, addition of 50 mL fresh medium) and 50 mL of eachThis journal is © The Royal Society of Chemistry 2014




























































































View Article Onlinepolyplex solution were added. The E-plate was put in the incu-
bator for 20 min to allow equilibration. Then, the compound
activity monitoring step was started (measurement every 30 s for
6 h, aerwards every 15 min for 40 h).
The cell viability was additionally investigated in 786-O-Luc
tumor cells following amphiphile treatment. Cells were
cultured in 96-well plates at a density of 1  104 cells per well.
Aer 24 hours the growth medium was discarded and replaced
by 100 mL Opti-MEM (Gibco). The amphiphiles G1-Ester-DAPMA
(A1) and G2-Ester-DAPMA (A2) were dissolved in water and
complexed with luciferase specic (GCAAGAUCGCCGU-
GUAAUAUU, Dharmacon) or non-targeting siRNA (ON-TAR-
GETplus Non-targeting siRNA, Dharmacon) by incubating
5 pmol siRNA with corresponding amounts of amphiphiles
depending on N/P ratios 10, 20, and 30. Lipofectamine RNAi-
MAX transfection reagent (Invitrogen) was used as the positive
control following the manufacturer's protocol. Untreated cells
were used as the negative control. In a total volume of 50 mL the
polyplexes were added to the cells and incubated for 24 h at
37 C, which was then replaced by RPMI growth medium and
incubated for another 24 h. To determine the number of viable
cells within this study, the CellTiter-Glo Luminescent Cell
Viability Assay (Promega) was used according to the manu-
facturer's protocol.
Transfection study. The transfection eﬃcacy of the amphi-
philes was examined via quantitation of rey luciferase
reporter gene activity from treated 786-O-Luc cells. Therefore,
the same treatment procedure as for the cell viability assay with
786-O-Luc cells was used. Luciferase activity was measured
using the Luciferase Assay System (Promega) according to the
manufacturer's protocol. The luminescence signal was detected
via a Tecan Innite 200Pro.
Determination of pro-inammatory cytokines. To determine
the eﬀect of G1-Ester-DAPMA (A1) and G2-Ester-DAPMA (A2) on
the cytokine secretion in vivo, three BALB/c mice (Charles River)
per group were treated intravenously with A1 and A2 at doses of
8 mg kg1 and 20 mg kg1, respectively, complexed with non-
targeting siRNA (ON-TARGETplus Non-targeting siRNA, Dhar-
macon) at N/P 25. Invivofectamine 2.0 Reagent (Invitrogen) was
complexed with non-targeting siRNA according to the manu-
facturer's manual and used as the positive control. HyPure
water was administered as the negative control. Retrobulbar
blood was taken 1 h aer administration and serum was har-
vested. Cytokine levels in the serum were determined using the
Meso Scale Discovery Multi-Spot Assay System, Mouse ProIn-
ammatory 7-Plex Assay Ultra-Sensitive Kit corresponding to
the manufacturer's protocol.Synthesis
General procedure for the synthesis of compounds 6 and 7.
Stearoyl chloride 1 (18.8 g, 62.4 mmol for 2/2.6 g, 8.61 mmol for
3), and acetal protected dendrons 2 (10.0 g, 31.2 mmol) or 3
(3.0 g, 4.3 mmol) were dissolved in 25 mL of THF and cooled to
0 C in an ice bath. Triethylamine (8.6 mL, 62.4 mmol for
2/1.2 mL, 8.61 mmol for 3) was then added and the reaction
mixture was stirred rst at 0 C for 2 h and then at roomThis journal is © The Royal Society of Chemistry 2014temperature, overnight. The solution was concentrated to
dryness under vacuum, and the residue was taken up in chlo-
roform (25 mL) and water (5 mL). The organic layer was sepa-
rated, washed with saturated sodium chloride (2  15 mL) and
water (2  15 mL), and dried over MgSO4. The solvent was
removed under vacuum, and the crude esteried product was
directly used for the next step. The crude product was treated
overnight with a mixture of triuoroacetic acid–methanol (1 : 3)
to remove the acetal groups. The reaction mixture was then
evaporated under reduced pressure and puried via column
chromatography (eluent CHCl3–MeOH, 90 : 20) to aﬀord the
desired amphiphiles 6 and 7 as viscous oils in 75% and 65%
yields, respectively.
Compound 6. Obtained as a viscous oil (11.8 g, 75% over two
steps). 1H NMR (MeOD-d4, 400 MHz) d 0.88 (3H, t, J ¼ 6.9 Hz,
alkyl CH3), 1.27 (28H, s, alkyl CH2), 1.56–1.64 (2H, m, CH2–CH2–
O), 2.29–2.37 (2H, m, CH2–CH2–CO–O), 3.43–3.67 (13H, m,
dendron), 3.68–3.77 (2H, m, dendron); 13C NMR (MeOD-d4, 101
MHz) d 13.18, 22.44, 24.73, 24.73, 28.88, 28.92, 29.14, 29.14,
29.19, 29.33, 29.50, 31.78, 33.67, 33.89, 48.55, 63.08, 69.79,
70.84, 70.98, 71.16, 71.46, 72.54, 72.66, 77.28, 173.69. HRMS: m/
z calcd for C27H54O8Na [M + Na]
+: 529.3711. Found: 529.3696.
Compound 7. Obtained as a viscous oil (2.2 g, 65% over two
steps). 1H NMR (MeOD-d4, 400 MHz) d 0.88 (3H, t, J ¼ 6.9 Hz,
alkyl CH3), 1.27 (28H, s, alkyl CH2), 1.56–1.64 (2H, m, CH2–CH2–
O), 2.33 (2H, t, J ¼ 7.4 Hz, CH2–CH2–CO–O), 3.43–3.55 (25H, m,
dendron), 3.61–3.67 (5H, m, dendron), 3.73–3.77 (5H, m, den-
dron); 13C NMR (MeOD-d4, 101 MHz) d 13.30, 22.49, 24.80,
28.96, 29.24, 29.43, 29.57, 31.82, 33.94, 63.17, 68.66, 69.84,
70.87, 71.02, 71.12, 71.63, 71.71, 72.12, 72.64, 72.67, 78.46,
78.55, 78.60, 173.72. HRMS: m/z calcd for C39H78O16Na [M +
Na]+: 825.5188. Found: 825.5192.
General procedure for the synthesis of compounds 8 and 9.
The reaction was performed under an inert gas atmosphere and
exclusion of water. A solution of p-nitrophenyl chloroformate
(4.76 g, 23.6 mmol, 12 eq.) in 20 mL dry DCM was added
dropwise to dry DCM (20 mL) and dry pyridine (0.30 mL, 23.6
mmol, 12 eq.), while stirring at 0 C in an ice bath. On addition,
a white precipitate was formed. Subsequently, a solution of
compound 6 (1.0 g, 1.97 mmol, 1 eq.) or 7 (300 mg, 0.37 mmol, 1
eq.) dissolved in dry DCM (60 mL) and dry pyridine (0.37 mL,
23.6 mmol, 1.2 eq.) was added at 0 C via a dropping funnel over
a period of 2 h. The mixture was stirred in a thawing ice bath for
14 h. The reaction mixture was then diluted with DCM (50 mL)
and washed with NaHSO4 (2  50 mL, 1.33 M) and sat. brine
(50 mL). The organic phase was dried over MgSO4, ltered, and
the ltrate evaporated in vacuo. The reaction mixture was
roughly puried by HPLC (silica column, DCM–MeOH 98 : 2,
64 mLmin1). Due to the relative instability and since thorough
purication was not required at this stage, the intermediates 8
and 9 were used in their crude form for further synthesis.
General procedure for the synthesis of compounds 11 and
12. Each solution of the crude compounds 8 (500 mg,
0.43 mmol) or 9 (175 mg, 0.08 mmol), which were dissolved in
dry DCM (120 mL), was added dropwise over 2 h at 0 C into a
solution of mono-Boc-DAPMA (1.24 g, 5.08 mmol, 12 eq., dis-
solved in 50 mL dry DCM) employing dry reaction conditions.J. Mater. Chem. B, 2014, 2, 2153–2167 | 2157




























































































View Article OnlineImmediately, the solution turned yellow due to the displace-
ment of p-nitrophenol. A solution of DMAP (0.20 g, 1.69 mmol,
0.5 eq. per p-nitrophenyl branch) and DIPEA (0.15 mL,
1.69 mmol, 1.0 eq. per p-nitrophenyl branch) in dry DCM
(30 mL) was added and the reaction mixtures were stirred at
room temperature for 72 h. The solvent was then removed
under reduced pressure. Purication was performed both by
column chromatography (CHCl3–MeOH–NH4OH 90 : 9 : 1) and
size exclusion chromatography (SEC) using a Sephadex™ LH-20
(CHCl3–MeOH 1 : 1). Drying under high vacuum yielded the
products 11 and 12 as yellowish oils.
Compound 11. Obtained as a yellowish viscous oil (1.57 g,
50%). 1H NMR (MeOD-d4, 500 MHz) d 0.89 (3H, t, J ¼ 6.7 Hz,
alkyl CH3), 1.28 (28H, s, alkyl CH2), 1.43 (36H, s, Boc CH3), 1.59–
1.63 (2H, m, CH2–CH2–CO–O), 1.64–1.74 (16H, m, NH–CH2–
CH2), 2.30 (12H, s, N–CH3), 2.32–2.37 (2H, m, CH2–CH2–CO–O),
2.49 (16H, brs, CH2–N–CH3), 3.07 (8H, t, J ¼ 6.7 Hz, CH2–NH),
3.10–3.16 (8H, m, CH2–NH), 3.51–3.81 (9H, m, dendron), 4.04–
4.30 (6H, m, dendron); 13C NMR (MeOD-d4, 126 MHz) d 13.17,
22.43, 24.76, 26.53, 26.63, 27.54, 28.90, 28.94, 29.15, 29.35,
29.49, 31.77, 33.68, 33.89, 38.22, 38.71, 40.78, 53.50, 54.75,
54.82, 63.24, 69.76, 71.20, 78.65, 156.84, 157.21, 173.89. HRMS:
m/z calcd for C79H155N12O20 [M + H]
+: 1592.1481. Found:
1592.1414.
Compound 12. Obtained as a yellowish viscous oil (0.45 g,
40%). 1H NMR (MeOD-d4, 400 MHz) d 0.88 (3H, t, J ¼ 6.7 Hz,
alkyl CH3), 1.28 (28H, s, alkyl CH2), 1.41 (72H, s, Boc CH3), 1.62–
1.69 (34H, m, CH2–CH2–CO–O & NH–CH2–CH2), 2.15, 2.20 &
2.23 (24H, s, N–CH3), 2.31–32 (2H, m, CH2–CH2–CO–O), 2.36–
2.43 (32H, m, CH2–N–CH3), 2.99–3.06 (32H, m, CH2–NH), 3.09–
3.12 (8H, m, dendron), 3.51–3.75 (21H, m, dendron), 4.06–4.25
(6H, m, dendron); 13C NMR (MeOD-d4, 176 MHz) d 174.88,
158.47, 149.32, 79.97, 76.40, 72.52, 71.28, 64.66, 56.37, 55.91,
54.57, 53.89, 47.48, 42.58, 41.08, 39.90, 39.77, 39.25, 35.06,
32.99, 30.55, 30.49, 30.27, 30.11, 29.00, 27.88, 26.12, 25.23,
23.69, 14.35. HRMS: m/z calcd for C143H280N24O40 [M + 2H]
2+:
1487.0228. Found: 1487.0299.
General procedure for the synthesis of compounds A1 and
A2. TFA (6.0 mL, excess) was slowly added to a solution of
compounds 11 (0.10 g, 0.06 mmol) or 12 (0.10 g, 0.03 mmol) in
DCM (6.0 mL) and stirred overnight at room temperature. The
solvent was removed in vacuo and the residue washed alter-
nately with hexane and diethyl ether. Purication was accom-
plished via SEC (Sephadex™ LH20, MeOH) to remove any trace
amounts of impurities. Freeze drying yielded the compounds A1
and A2 as white foams.
Compound A1. Obtained as a white foam (98 mg, quant.). 1H
NMR (MeOD-d4, 500 MHz) d 0.88 (3H, t, J ¼ 6.7 Hz, alkyl CH3),
1.28 (28H, s, alkyl CH2), 1.57–1.60 (2H, m CH2–CH2–CO–O), 1.93
(8H, brs, NH–CH2–CH2), 2.11–2.14 (8H, m, NH–CH2–CH2), 2.31–
2.34 (2H, m, CH2–CH2–CO–O), 2.88 & 2.89 (12H, s, N–CH3),
3.03–3.06 (8H, m, CH2–N–CH3), 3.19–3.28 (24H, m, 8  CH2–N–
CH3 & 16  CH2–NH), 3.59–3.73 (9H, m, dendron), 4.02–4.33
(6H, m, dendron), 13C NMR (MeOD-d4, 126 MHz) d 13.10, 22.17,
22.39, 24.49, 24.75, 24.77, 28.88, 28.92, 29.12, 29.32, 29.45,
31.73, 33.67, 33.90, 36.49, 37.40, 39.10, 52.91, 54.07, 63.26,
69.70, 69.84, 71.35, 157.10, 157.46, 162.08 (CF3COOH) 174.00.2158 | J. Mater. Chem. B, 2014, 2, 2153–2167HRMS:m/z calcd for C59H123N12O12 [M + H]
+: 1191.9378. Found:
1191.9376.
Compound A2. Obtained as a white foam (131 mg, quant.).
1H NMR (MeOD-d4, 400 MHz) d 0.89 (3H, t, J ¼ 6.7 Hz, alkyl
CH3), 1.28 (28H, s, alkyl CH2), 1.58–1.60 (2H, m, CH2–CH2–CO–
O), 1.94 (16H, brs, NH–CH2–CH2) 2.12–2.14 (16H, m, NH–CH2–
CH2), 2.31–2.34 (2H, t, J ¼ 7.0 Hz, CH2–CH2–CO–O) 2.89, 2.90
(24H, s, N–CH3), 3.03–3.06 (16H, m, CH2–N–CH3), 3.19–3.26
(48H, m, 16  CH2–N–CH3 & 32  CH2–NH), 3.51–3.73 (29H, m,
dendron), 4.03–4.07 (3H, m, dendron), 4.31–4.33 (3H, m, den-
dron); 13C NMR (MeOD-d4, 176 MHz) d 173.71, 161.70, 161.51,
157.34 & 156.97 (TFA), 115.92 & 113.84 (TFA), 71.29, 70.85,
69.94, 69.71, 68.62, 63.29, 53.99, 52.94, 52.81, 39.00, 37.37,
36.40, 33.92, 31.65, 29.35, 29.11, 29.05, 28.86, 24.76, 24.37,
22.31, 22.09, 13.03. HRMS: m/z calcd for C103H216N24O24 [M +
2H]2+: 1086.8204. Found: 1086.8152.
Results and discussion
Synthesis
Four distinct low-molecular-weight amphiphilic constructs (cf.
Fig. 2) have been synthesized diﬀering in linker chemistry and
dendron generation. Thus, specic properties with reference to
biodegradability, size, and the number of multivalent interac-
tions were introduced in order to create an eﬃcient gene carrier
with a particular attributed structural motif. The potential gene
vectors were designed to utilize hydrophilic polyglycerol den-
drons of two diﬀerent generations [G1, G2] combined with a
simple C-18 alkyl chain representing the hydrophobic domain,
in order to unite the advantageous features of both lipid and
dendritic gene delivery vehicles. As mentioned above, it is
necessary to modify the dendritic polyglycerol scaﬀold with a
hydrophobic unit to allow the formation of multivalent supra-
molecular architectures and thus facilitate eﬃcient complexa-
tion and condensation of the genetic material, which is an
important prerequisite for transfection ability.27
Due to their water solubility and physiological safety, which
is based on a very biocompatible glycerol building block,59
polyglycerol dendrons were selected to serve as the hydrophilic
part within the amphiphilic structure. As a dendritic scaﬀold,
they provide multiple hydroxyl groups which can be syntheti-
cally modied, thus oﬀering the opportunity for multivalent
interactions with biological substrates,60 resulting in consider-
ably stronger binding aﬃnities compared to monovalent
interactions.61 In addition, the degree of functionality and thus
the size can be varied by choosing a certain dendron generation.
Here, the amphiphiles were functionalized at their periph-
eral positions with a particular triamine: N,N-di-(3-amino-
propyl)-N-(methyl)amine (DAPMA) that already proved to be an
eﬀective entity for gene delivery purposes.49 It is known for a few
decades now that in the presence of multivalent cations, such as
the naturally occurring oligoamines spermine and spermidine,
DNA undergoes a dramatic condensation to a compact, usually
highly ordered structure,62 which is essential for the gene
delivery process, since as one of the rst steps the genetic
material needs to be transported eﬃciently through the cellular
membrane. In the specic case of DAPMA, it has been suggestedThis journal is © The Royal Society of Chemistry 2014




























































































View Article Onlinethat the sterically hindered tertiary amine deforms DNA in
order to achieve the interactions, resulting in strong local
binding and thus in eﬃcient DNA compaction.49 Moreover, this
specic triamine ligand has been shown to lower the toxicity
when compared with diamine- and tetraamine modiedScheme 1 Synthesis of G1-Ester-DAPMA (A1) and G2-Ester-DAPMA (A2
This journal is © The Royal Society of Chemistry 2014dendrons.49 In addition to that, it is believed that primary amine
groups generally participate in nucleic acid binding, condense
it into nanoscale particles and promote its cellular uptake,
while tertiary amines may act as “proton sponge” entities in
endosomes and enhance the release of the genetic material into).
J. Mater. Chem. B, 2014, 2, 2153–2167 | 2159






































































































View Article Onlinethe cytoplasm.63 Therefore, we reason that this specic amine
unit (DAPMA) is an ideal candidate for gene delivery
applications.
Besides the dissimilarity in the size of the hydrophilic head
group by using diﬀerent generations of polyglycerol dendrons
(G1, G2), variations were also introduced regarding their
degradation prole that may assist the eﬃcient release of the
nucleic acids from the polyplex. Therefore, two amphiphiles
were equipped with a biodegradable ester bond at the focal
point [G1-Ester-DAPMA (A1), G2-Ester-DAPMA (A2)] in contrast
to a non-degradable rigid triazole linker within the other two
scaﬀolds [G1-Trz-DAPMA (A3), G2-Trz-DAPMA (A4)] (cf. Fig. 2).
For the synthesis of G1-Ester-DAPMA (A1) and G2-Ester-
DAPMA (A2) (Scheme 1), we rst reacted each of the acetal group
protected polyglycerol dendrons [G1.0]-OH (2) and [G2.0]-OH (3)
with commercially available stearoyl chloride (1), thereby
forming an ester bond at the focal point which represents a
biodegradable connection between both domains of the
amphiphile. Aer removing the 1,2-diol protecting groups
under acidic conditions, the peripheral hydroxyl entities were
converted into activated carbonate functionalities by using
p-nitrophenyl chloroformate. In the next step, mono-Boc-pro-
tected DAPMA units (10) were attached via nucleophilic
substitution to the dendritic backbone of compounds 8 and 9 in
50% and 40% yield over two steps, respectively, involving the
liberation of p-nitrophenol. The Boc-protected species 11 and 12
were then treated overnight with TFA to aﬀord G1-Ester-DAPMA
(A1) and G2-Ester-DAPMA (A2) in quantitative yields, as their
triuoroacetate salts (Scheme 1).
Regarding the synthesis of the amphiphiles G1-Trz-DAPMA
(A3) and G2-Trz-DAPMA (A4), the hydroxylated, non-degradable
precursors (13, 14; cf. ESI, Scheme S1†) were initially generated
according to our previously published procedure.27 The DAPMA
functionalization of the dendron's deprotected surface occurred
in a similar fashion to those for the compounds 6 and 7.
Correspondingly, the free hydroxyl groups of the triazole-
bridged amphiphiles (13, 14; cf. ESI, Scheme S1†) were con-
verted into the respective carbonate species (15, 16; cf. ESI,
Scheme S1†), followed by the addition of mono-Boc-protected
DAPMA (10) in the presence of DMAP and DIPEA, to give the
aminated triazole amphiphiles (17, 18; cf. ESI, Scheme S1†) in
39% and 27% yields over two steps, respectively. Aer the nal
treatment with triuoroacetic acid, the two triazole-based target
molecules G1-Trz-DAPMA (A3) and G2-Trz-DAPMA (A4) were
obtained in quantitative yields (cf. ESI, Scheme S1†).A1 2.9  10 n.a. 4.0 ( 0.2) 51.7 ( 5.2)
A2 1.6  103 3.4  0.2 3.0 ( 1.0) 41.5 ( 4.2)
A3 2.7  103 n.a.e 5.0 ( 0.2) 52.9 ( 5.3)
A4 1.3  103 3.8  0.5 3.0 ( 1.0) 42.7 ( 4.3)
a HEPES saline buﬀer (pH 7.4, 9.4 mM NaCl). T ¼ 25 C. b Pyrene
concentration: 0.5 mM. c Phosphate buﬀer (pH 7.4, 10 mM);
c ¼ 4.5 mM. T ¼ 25 C. Size distribution by volume, PDI ¼ 0.2–0.4.
d c ¼ 4.5 mM. TEM diameter values of micelles are estimated from
individual micelles in the case of G2 derivatives; in the case of the G1
species, areas of two-dimensionally ordered spherical micelles were
analyzed in reciprocal space (Fourier analysis), where diﬀraction rings
indicate the mean micelle diameter. e G1 derivatives turned out to
assemble towards extended two-dimensionally ordered structures
besides spherical micelles. Because of this structural bimodality DLS
measurements are not applicable.66Physico-chemical characterization of amphiphiles A1–A4
Amphiphiles generally tend to aggregate towards micellar
assemblies in aqueous media due to the hydrophobic eﬀect.64
By suitable synthetic modication of the head group and
balancing the hydrophobic tail, even structurally persistent
supramolecular architectures can be generated,65,66 which stand
in contrast to conventional micelles that form loose, short-lived
dynamic aggregates. This particular behavior can, for instance,
be exploited for transporting therapeutic material like genes,
particularly if the head group exposes a positive net charge that2160 | J. Mater. Chem. B, 2014, 2, 2153–2167enables electrostatic interactions with negatively charged
nucleic acids.
To examine the physico-chemical characteristics of the
synthesized dendritic amphiphiles A1–A4 and to evaluate their
applicability as potential gene delivery systems, the aggregation
behavior as well as size and surface charge were studied using
diﬀerent physical characterization methods such as critical
micelle concentration (CMC) determination, cryogenic trans-
mission electron microscopy (cryo-TEM), dynamic light scat-
tering (DLS), and zeta potential measurements (Table 1).
Initially, the aggregation of the amphiphiles was studied via
determination of the CMC values, since self-assembly of
amphiphilic entities and thus formation of thermodynamically
stable micellar aggregates only occurs, when the concentration
of the amphiphile exceeds a critical concentration, known as
the CMC. In fact, the CMCs were identied by means of uo-
rescence spectroscopy using pyrene as a uorescence probe in
aqueous solution. This hydrophobic dye is a preferred uores-
cent probe due to its strong uorescence in nonpolar domains
and its weak radiation in polar media. Upon micellization,
pyrene partitions preferentially into the hydrophobic micro-
domain of the micelles which is accompanied by a sharp
increase in uorescence.
The determined CMC values given in Table 1 show that all
four amphiphiles (A1–A4) self-assemble at a millimolar level
ranging from 1.3–2.9 mM. These rather high CMC values can be
ascribed to the high cationic charge density, which is the result
of the conjugated oligoamine surface ligand DAPMA. This is
especially true, when comparing the CMCs of G1-Trz-DAPMA
(A3) and G2-Trz-DAPMA (A4) to similar constructs27 that only
diﬀer in the attached amine unit and exhibit CMC values in the
micromolar range (10–60 mM). Interestingly, the G2 amphi-
philes (A2, A4) possess slightly lower CMC values than their G1
counterparts (A1, A3). A similar observation has been made by
Trappmann et al., who showed that in their case a larger degree
of hydrophilicity can lead to lower CMC values.66 As expected,
the diﬀerent spacer units only had a small eﬀect on the CMC,
since G1-Trz-DAPMA (A3) and G2-Trz-DAPMA (A4), whichThis journal is © The Royal Society of Chemistry 2014




























































































View Article Onlinecomprise a triazole ether linkage, exhibited slightly lower CMC
values than the ester-bridged, less hydrophobic analogs, G1-
Ester-DAPMA (A1) and G2-Ester-DAPMA (A2).
The aggregation behavior was further studied by DLS, which
allows determination of hydrodynamic diameters (dH). As
shown in Table 1, the G2 amphiphiles A2 and A4 formed very
small micelles with diameters between 3 and 4 nm. Surpris-
ingly, these values are in the same range as the theoretical size
of the amphiphilic monomer units G2-Ester-DAPMA (A2) and
G2-Trz-DAPMA (A4) (3.3–3.6 nm), which indicates that the
formed spherical particles are only composed of a small
number of self-assembled amphiphiles, presumably dimers. In
the case of generation one amphiphiles G1-Ester-DAPMA (A1)
and G1-Trz-DAPMA (A3), the obtained DLS values could not be
used because cryo-TEM measurements signied a bimodal
aggregation behavior (see below).
In order to supplement the described aggregation phenomena
in the case of A2 and A4 by a direct structural analysis and to
elucidate the self-assembly behavior of G1-Ester-DAPMA (A1) and
G1-Trz-DAPMA (A3), cryo-TEMmeasurements were performed on
aqueous sample solutions at a general concentration of 4.5 mM,
which is well above the amphiphiles' corresponding CMC values.
All amphiphiles (A1–A4) showed a tendency to form small
spherical particles, though the respective G1 derivatives A1 and
A3 revealed a second supramolecular species by showing a more
complex two-dimensionally ordered hexagonal aggregation
pattern (cf. Fig. 3). This nding renders DLS measurements non-
applicable in the particular case of A1 and A3. The relevance of
the second assembly phenomenon is not yet fully understood
and remains to be claried in future investigations.
The spherical particles formed by all four amphiphiles (A1–
A4) showed diameters in the range of 3–5 nm and did not
denote internal structural diﬀerentiations. Interestingly, the
diameters are far below the values obtained from the dendritic
non-ionic analogs,66 where dimensions and density proles
indicate the formation of molecular bilayer structures. Due to
the presence of the strongly hydrated amine sphere and hence
the corresponding large head group volume, we suppose that
small assemblies consisting of only very few molecules are
obtained. For geometrical reasons this might even lead to the
formation of dimeric assemblies in the case of the G2 deriva-
tives A2 and A4. It is further assumed that in such a dimeric
assembly the diameter of the head groups (2–4 nm) determines
the whole size of the assemblies, whereas hydrophobic alkyl
chains can be easily accommodated within the core volume
without a signicant impact on the overall assembly size.
In accordance with the large number of peripheral amine
groups, the conducted zeta measurements (Table 1) showed
that all four compounds displayed high positive surface charges
between 41 and 53mV, which supports the applicability of these
systems as prospective gene carriers. Interestingly, the G1
amphiphiles A1 and A3 exhibited slightly higher surface
charges, which presumably relates to the diﬀerent aggregation
patterns observed with these compounds. Moreover, this can be
explained by less repulsion of the positive charges within the
hydrophilic head groups of the generation one amphiphiles, as
already observed for related structures.27,47This journal is © The Royal Society of Chemistry 2014Oligonucleotide binding and condensation
The process of eﬃcient binding and condensation of oligonu-
cleotides represents an elemental step within the gene delivery
route, since it enables the cellular internalization of the genetic
material. Due to the fact that cell membranes are typically
negatively charged owing to their content of glycoproteins,
proteoglycans, and glycerolphosphates,67,68 the complex
between the gene carrier and the nucleic acid, termed polyplex,
should preferentially exhibit a positive net charge for eﬀectively
penetrating the cell membrane. Moreover, the induced
complexation of the genetic material causes its collapse and
condensation due to the decrease of the repulsive forces
between the anionic charges. As a result, much smaller oligo-
nucleotide particles are formed which can be endocytosed by
the cell.
Notably, increasing the net positive surface charge of
polyplexes will promote the uptake but also raise cytotoxicity
due to membrane destabilization. Accordingly, the complexes
have to strike a balance between cellular uptake and cytotoxicity
to achieve optimal delivery eﬃciencies. Hence, only the actually
required amount of nitrogen atoms or rather cationic charges
should be employed. This can be realized by nding the
appropriate N/P ratio which describes the molar ratio of amine
(N) to phosphate (P) groups. Relevant N/P ratios have to be
determined individually since they are dependent on a variety of
factors such as size, shape, charge, and ligand modication of
the used gene carrier.
In order to examine the ability of the synthesized
compounds A1–A4 to eﬃciently complex and condense the
genetic material, the binding aﬃnity to DNA was studied rst by
using the ethidium bromide (EthBr) displacement assay (cf. ESI,
S11–S13 for additional information†). Although the resulting
data rather reect a competition assay than an absolute binding
strength, it is a powerful comparative method, because it gives
valuable information about the gene carriers' general tendency
to bind oligonucleotides.55 According to the obtained, very low
CE50 values (0.3) (cf. ESI, Table S1†) – that generally reect the
relative ability to bind anionic DNA per cationic charge – all
scaﬀolds (A1–A4) proved to be overall strong DNA binders. This
is supported by CE50 values of dendritic amphiphiles that were
decorated with primary amine groups.27 There, the DNA
binding was signicantly weaker as CE50 values of 0.8–1.3 were
obtained. In contrast to the currently employed triamine unit
(DAPMA), a simple glycine unit (monoamine) was connected to
each dendron branching in that case, thereby indicating the
benecial eﬀect of using an inherently multivalent amine
group, such as DAPMA.
The binding capacity of all four amphiphiles (A1–A4) was
further investigated using the agarose gel electrophoresis
retardation assay that directly measures interactions between
oligonucleotides and potential gene carriers. As a sign of
successful DNA or RNA neutralization and condensation, the
constructs should either reduce or completely retard the elec-
trophoretic mobility of the genetic material. The obtained
results (Fig. 4) show that all four amphiphiles (A1–A4) are able
to eﬃciently complex and condense siRNA at N/P ratios betweenJ. Mater. Chem. B, 2014, 2, 2153–2167 | 2161
Fig. 4 Binding capacity andmigration of amphiphile–siRNA complexes using agarose gel electrophoresis. Complexes of FAM-labeled siRNA and
the amphiphiles G1-Ester-DAPMA (A1), G2-Ester-DAPMA (A2), G1-Trz-DAPMA (A3), and G2-Trz-DAPMA (A4) with increasing N/P ratios (lane
1–7: 5, 10, 20, 30, 50, 70, and 100, each) are shown. Complex-free FAM-siRNA (siRNA) and Lipofectamine 2000 complexed FAM-siRNA (Lipo) are
displayed in the last two slots on the right. Images were acquired by detecting the green ﬂuorescence signal.




























































































View Article Online10 and 20. Complex-free siRNA and a complex of siRNA and
Lipofectamine 2000 were loaded as controls. In accordance with
the results obtained by the EthBr assay, the G2 derivatives (A2,
A4) are slightly more eﬃcient than their lower generation
counterparts (A1 and A3), i.e., amphiphile G2-Ester-DAPMA (A2)
reduces the siRNA mobility at N/P 10 to a more pronounced
extent than G1-Ester-DAPMA (A1).
As mentioned above, in order to facilitate eﬃcient gene
expression, on the one hand, slightly positively charged poly-
plexes are believed to promote interactions with predominantly
negatively charged cell membranes.67,68 On the other hand, the
process of DNA/siRNA condensation plays a vital role in the
transfection pathway. Therefore, the hydrodynamic diameters
plus surface charges of the amphiphile–DNA polyplexes were
then determined by DLS and zeta potential measurements.
The obtained data (Fig. 5) indicate that all four compounds
(A1–A4) which already exhibited high DNA binding aﬃnities,
as revealed by the EthBr assay as well as by gel electrophoresis
studies, in turn condense DNA eﬀectively into polyplexes of
200 nm in diameter, at N/P ratios 10–20. Predictably, on
raising the N/P ratios, the complexed oligonucleotides areFig. 5 Hydrodynamic diameter (size) and zeta potential of DNA polyplex
and 20). Amphiphile–DNA polyplexes weremeasured in HEPES saline buﬀ
0.4. Zeta potential of DNA ¼ 29.5  3.2 mV (size not determinable, du
2162 | J. Mater. Chem. B, 2014, 2, 2153–2167condensed to a more pronounced extent which leads to
smaller polyplexes. However, relatively large polyplex particles
have been observed with lower N/P ratios (N/P 2–5), which
underlines the necessity of applying a minimum N/P ratio of
10 for all four amphiphiles (A1–A4) to yield suﬃciently
condensed polyplexes that are able to be internalized by cells
(ca. 200 nm).
The conducted zeta potential measurements give overall
positive net charges ranging from 12–28 mV. Interestingly, even
at the lowest N/P ratio of 2, positive net charges can still be
detected with every amphiphilic transporter (A1–A4) which
reects the strong interaction and as a result leads to a
reasonable neutralization of the DNA. In accordance with the
DLS results, the identied zeta potentials of the polyplexes
illustrate the general tendency that the zeta potential rises with
increasing N/P ratios, which is in agreement with theoretical
expectations.27 Although the concentrations of the sample
solutions were convenient for zeta potential and DLS
measurements, they turned out to be too low for cryo-TEM
investigations, so that direct structural data of polyplexes could
not be obtained under the experimental conditions used.es obtained with amphiphiles A1–A4 using varying N/P ratios (2, 5, 10,
er (pH 7.4, 9.4 mMNaCl). DLS size distribution by volume, PDI¼0.1–
e to high polydispersity).
This journal is © The Royal Society of Chemistry 2014




























































































View Article OnlineIn vitro cytotoxicity
Cytotoxicity is an important aspect to be considered when
evaluating nanocarriers for their specic transfection potency.
Therefore, the cytotoxic potential of all four amphiphiles (A1–
A4) was determined by the WST-1 assay as well as by the
xCELLigence system (Roche) using non-targeting (nT) siRNA
and HeLa cells. As mentioned earlier, the most appropriate N/P
ratio has to be a compromise between suﬃcient complexationFig. 6 Cytotoxicity determined by the two diﬀerent methods: WST-1 ass
targeting (nT) siRNA. The results of the WST-1 assay (A–D) and of the xCELL
treated with nT siRNA, but without transfection reagent (WST-1 assay ¼ 1
(integrated within the xCELLigence graphics) characterizes untreated cells. N
DAPMA (A1) is shown in panels A and E, G2-Ester-DAPMA (A2) in B and F,
This journal is © The Royal Society of Chemistry 2014and release of the siRNA together with low cytotoxicity and high
transfection eﬃciency. In order to cover a broad range of
possible N/P ratios and in accordance with the ndings
extracted from the gel retardation assay, amphiphile–siRNA
polyplexes with N/P 10, 30, and 50 were evaluated.
The results of the WST-1 assay (Fig. 6A–D) relative to nT
siRNA treated cells (control cells which were treated with nT
siRNA but without transfection reagent; henceforth referred toay (left) and xCELLigence (right). HeLa cells were transfected with non-
igence system (E–H) are shown relative to nT siRNA control cells that are
(dashed line); xCELLigence ¼ 0 (baseline)). The control group “Control”
/P ratios 10, 30, and 50 were analyzed for all four amphiphiles. G1-Ester-
G1-Trz-DAPMA (A3) in C and G, and G2-Trz-DAPMA (A4) in D and H.
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Fig. 7 786-O Luc transgenic cells were transfected with luciferase
speciﬁc and non-targeting siRNA (ON-TARGETplus Non-targeting
siRNA, Dharmacon) complexed with nanocarriers A1 and A2 at N/P
ratios of 10, 20, and 30 for 48 h. Lipofectamine was used as a positive
control and untreated cells as the negative control. (A) Cell viability was
measured by using the CellTiter-Glo Luminescent Cell Viability Assay
(Promega). (B) Transfection eﬃcacy was determined by using the
commercial Luciferase Assay System (Promega). Results are shown as
mean  SD of triplicates.




























































































View Article Onlineas “nT siRNA cells”) illustrate that all examined amphiphiles
(A1–A4) showed no toxicity while using an N/P ratio of 10.
Furthermore, siRNA polyplexes at N/P 30 formulated with G1-
Ester-DAPMA (A1) and G2-Ester-DAPMA (A2) did not show
considerable toxic eﬀects. However, G2-Trz-DAPMA (A4)
induced a decrease of cell viability at N/P 30 (61% reduction) as
well as to some extent G1-Trz-DAPMA (A3) (31% reduction),
indicating a higher cytotoxic potential for the triazole deriva-
tives when compared to the ester-linked analogs (A1: 7% and
A2: 28% reduction). At N/P 50 all amphiphiles led to a reduction
of cell viability by at least 54% (i.e., A1) (A2: 70%), which was
again found to be more pronounced in the case of the triazole-
bridged amphiphiles (A3: 79%, A4: 99%). Therefore, an N/P
ratio well below 50 was used for subsequent transfection studies
with all four nanotransporters (A1–A4).
In addition, the cytotoxicity of the nanocarriers was investi-
gated by the xCELLigence system (Fig. 6E–H) for continuous
monitoring of cell viability and growth in real-time. The data
from the xCELLigence system were normalized to the time
before transfection (24 h aer seeding) and were related to nT
siRNA cells, demonstrated as a baseline (delta cell index ¼ 0).
Proles from untreated cells (negative control, termed
“Control”) and cells treated with Lipofectamine (positive
control) served as references. Short-term rises (5 h period) of the
cell index aer amphiphile–siRNA polyplex treatment were
observed for all four nanocarriers A1–A4 (E–H), while A2 (F) and
A4 (H) led to stronger increases than the G1 analogs (A1, A3),
potentially caused by nontoxic changes in cell adhesion and cell
structure. Addition of Lipofectamine and the replacement of
culture medium in the control group (Control) showed a minor
eﬀect on the cell index. Generally, it can be stated that all
amphiphiles (A1–A4) induced no toxic long-term eﬀects as
observed by the xCELLigence system. Slight but non-signicant
decreases of the cell index compared to the controls (Control,
Lipofectamine) (i.e., A3 N/P 10, 24–50 h post-treatment) may
result from alteration of viability, adhesion, or cell structure
during transfection. The diﬀerences between the outcomes of
the two assay systems result from the varying methods, since
the WST-1 assay generally gives information about the mito-
chondrial metabolism activity which signies the endogenous
redox potential of cells, whereas the xCELLigence system relates
to changes of the cell impedance. In conclusion, although in
several cases there is a drop of detectable mitochondrial activity
at 48 h post-transfections (see above; WST assay), generally cell
morphology and numbers do not diﬀer signicantly within the
tested period of two days (xCELLigence system).In vitro siRNA transfection
The in vitro transfection eﬃcacy of amphiphile–siRNA complexes
was evaluated using luciferase as a reporter gene in the human
renal carcinoma cell line, 786-O-Luc. Due to the partial in vitro
cytotoxicity of certain amphiphiles seen in HeLa cells, the eﬀect
on the cell viability of 786-O-Luc by all four constructs (A1–A4)
was evaluated rst. No reduction of cell viability was determined
in A1 and A2 treated cells, as well as by the positive control Lip-
ofectamine compared to the untreated control cells (Fig. 7A).2164 | J. Mater. Chem. B, 2014, 2, 2153–2167However, the triazole-bridged compounds A3 and A4 revealed
enhanced cytotoxicity vs. the ester-linked constructs (cf. ESI,
Fig. S4A†), thereby conrming the eﬀect seen with HeLa cells.
Therefore, we focused on A1 and A2 for further studies.
The transfection eﬃcacy of the ester-linked amphiphiles A1
and A2 was largely inuenced by the given N/P ratio of the
amphiphiles (A1, A2)–anti-Luc-siRNA polyplexes, as shown in
Fig. 7B. Both A1 and A2 showed the highest knockdown eﬀect
using N/P 30 (38% and 27%, respectively). N/P 20 caused a
decrease of luciferase activity of 34% (A1) and 19% (A2) vs.
control. However, knockdown was less than that obtained with
Lipofectamine (positive control). Polyplexes with N/P 10
induced no reduction of luciferase expression. When using non-
targeting siRNA, the luciferase activity of A1 at N/P 30 was also
partially reduced, while the same applies to the A2 complexes
(with all three tested N/P ratios). Due to the fact that these
amphiphile–non-targeting siRNA complexes showed no cyto-
toxicity, an unspecic eﬀect can be assumed in this case. In
addition, polyplexes with an N/P ratio above 30 caused cyto-
toxicity (data not shown). An N/P ratio of 25 was therefore used
for the following investigation (determination of pro-inam-
matory cytokines). The triazole amphiphiles A3 and A4 showed,
in addition to enhanced cytotoxicity, no specic transfection
eﬃcacy (cf. ESI, Fig. S4B†).This journal is © The Royal Society of Chemistry 2014




























































































View Article OnlineThis divergence in transfection eﬃciency can be attributed
to the diﬀerent incorporated linker groups at the core of the
amphiphiles. The biodegradable and exible nature of the
ester linker unit (in A1 and A2) compared to a stiﬀ, non-
degradable triazole group present in A3 and A4 could be the
reason for the low cytotoxicity and enhanced transfection
activity for A1 and A2. It can be assumed that due to their high
positive surface charges and consequential strong nucleic
acid binding (as revealed by the conducted EthBr assay)
which is clearly the result of the incorporated amine moiety
DAPMA, the complexed siRNA presumably could not be
liberated eﬀectively in order to yield superior gene transfer
activities. Similar observations are known from other gene
carriers, as it can be diﬃcult to nd the delicate balance
between initial protection and subsequent release of the
genetic cargo.69,70Fig. 8 Three BALB/c mice per group were treated intravenously with 8 m
siRNA (ON-TARGETplus Non-targeting siRNA, Dharmacon) at an N/P rat
used as the negative control (vehicle). Retrobulbar blood was taken 1 h aft
Spot Assay System, Mouse ProInﬂammatory 7-Plex Assay Ultra-Sensitive
This journal is © The Royal Society of Chemistry 2014Determination of pro-inammatory cytokines
It is known that nanoparticles can induce pro-inammatory
responses in vivo as an adverse reaction which can therefore
constrict their administration.71 To evaluate if there are limi-
tations regarding the biological application of the relevant
amphiphiles A1 and A2 due to possible inammatory side
eﬀects, the impact of their systemic injection in mice on pro-
inammatory cytokine levels in blood was determined (Fig. 8).
BALB/c mice were treated intravenously with A1– and A2–non-
targeting siRNA complexes, respectively. Administration of Invi-
vofectamine (Invitrogen) was used as a positive control, HyPure
water as the negative control (vehicle). Blood was taken 1 h aer
administration and pro-inammatory cytokines were determined
in the serum. It was found that the secretion of the cytokines IL-6,
IL-1b, and TNF-a was not aﬀected by the treatment with A1 and
A2. Furthermore, A1 treatment did not lead to a change in serumg kg1 and 20 mg kg1 A1 (A) vs. A2 (B) complexed with non-targeting
io of 25, or Invivofectamine 2.0 Reagent, Invitrogen. HyPure water was
er injection and serumwas examined via a Meso Scale Discovery Multi-
Kit. Results are shown as mean  SD of triplicates.
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View Article Onlinecytokine levels of IL-10 and KC. The treatment with 20mg kg1 A2
N/P 25 caused a moderate increase of KC and IL-10 in the serum
in comparison to the vehicle control. Followed by the adminis-
tration of 20 mg kg1, both amphiphiles showed an increased
secretion of IFN-g compared to the negative control. However,
these measured average concentrations (A1: 5 pg mL1, A2: 16 pg
mL1) do not reect an acute inammatory response.72,73
Interestingly, the positive control Invivofectamine induced
higher levels of KC, IL-6, IL-10, and TNF-a compared to the
tested amphiphiles (A1, A2). In conclusion, the administration
of G1-Ester-DAPMA (A1) and G2-Ester-DAPMA (A2) caused no
induction of a pro-inammatory response compared to the
controls Invivofectamine and Hypure water. This lack of
inammatory side eﬀects is promising for the application of
this kind of delivery vehicle in vivo.
Conclusions
Within the scope of this work we have developed well-dened
low-molecular-weight amphiphilic polyglycerol dendrons that
display amine units in a multivalent fashion. The main
distinctions that have been introduced relate to their dendron
generation and the type of linker between the hydrophilic and
hydrophobic domains, i.e., an ester functionality (A1, A2) and a
triazole group (A3, A4). We have demonstrated that these
molecules are able to self-assemble into small, spherical
aggregates that exhibit high positive surface charges. By
utilizing diﬀerent physico-chemical techniques, such as DLS
and zeta potential measurements, ethidium bromide displace-
ment assay, and agarose gel electrophoresis, we showed that all
four amphiphilic dendrimers (A1–A4) are able to eﬀectively
complex and condense DNA and RNA. Diﬀerences within this
set of amphiphiles mainly emerged with regard to their bio-
logical performance. Although each amphiphilic dendrimer
had the ability to bind siRNA eﬀectively, only the ester-bridged
constructs, G1-Ester-DAPMA (A1) and G2-Ester-DAPMA (A2),
were able to result in a noticeable and target-specic reduction
of luciferase activity in 786-O cells in vitro without aﬀecting the
cell viability. Notably, A1 as well as A2 revealed no inammatory
side eﬀects aer systemic administration in mice compared to
the commercial transfection reagent “Invivofectamine” (Invi-
trogen). This is remarkable because such highly positively
charged compounds oen raise cytotoxicity issues,74–76 which
renders these dendritic structures particularly appealing for in
vivo gene delivery purposes.
In conclusion, due to their valuable physico-chemical prop-
erties, and in vitro siRNA transfection eﬃciencies, as well as
their safe in vivo prole, the ester-linked, DAPMA-functional-
ized dendritic amphiphiles (A1, A2) are promising candidates
for the development of in vivo delivery systems in the future.
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